A novel corticotropin-releasing factor receptor splice variant exhibits dominant negative activity: a putative link to stress-induced heart disease

A growing body of experimental and clinical studies supports a strong association between psychological stress and cardiovascular disease. An important endogenous cardioprotective role in heart physiology has been attributed to corticotropin-releasing factor receptor type 2 beta(CRFR2 beta). Here, we report the isolation of cDNA from mouse (m) heart encoding a novel CRFR2 beta splice variant. Translation of this insertion variant (iv)-mCRFR2 beta isoform produces a 421-aa protein that includes a unique C-terminal cytoplasmic tail. Our functional analysis and cellular localization studies demonstrated that when coexpressed with wild-type mCRFR2 beta, iv-mCRFR2 beta significantly inhibited the wild-type mCRFR2 beta membrane expression and its functional signaling by ER-Golgi complex retention, suggesting a dose-dependent dominant negative effect. Interestingly, mice exposed to a 4-wk paradigm of chronic variable stress, a model of chronic psychological stress in humans, presented significantly lower levels of mCRFR2 beta and higher levels of iv-mCRFR2 beta mRNA expression in their hearts, compared to nonstressed control mice. The dominant-negative effect of iv-mCRFR2 beta and its up-regulation by psychological stress suggest a new form of regulation of the mCRFR2 beta cardioprotective effect and a potential role for this novel isoform in stress-induced heart disease.-Sztainberg, Y., Kuperman, Y., Issler, O., Gil, S., Vaughan, J., Rivier, J., Vale, W., Chen, A. A novel corticotropin-releasing factor receptor splice variant exhibits dominant negative activity: a putative link to stress-induced heart disease. FASEB J. 23, 2186-2196 (2009)